- Home
- DCOM vs NVCR Comparison
DCOM vs NVCR Comparison
Compare DCOM & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DCOM | NVCR |
|---|---|---|
| Founded | 1864 | 2000 |
| Country | United States | Switzerland |
| Employees | 902 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | DCOM | NVCR |
|---|---|---|
| Price | $33.00 | $11.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $36.40 | $28.08 |
| AVG Volume (30 Days) | 224.8K | ★ 1.7M |
| Earning Date | 04-21-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $655,353,000.00 |
| Revenue This Year | $21.40 | $7.72 |
| Revenue Next Year | $12.65 | $6.74 |
| P/E Ratio | $14.81 | ★ N/A |
| Revenue Growth | N/A | ★ 8.28 |
| 52 Week Low | $23.25 | $9.82 |
| 52 Week High | $36.86 | $20.05 |
Technical Indicators
Market Signals| Indicator | DCOM | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 45.36 |
| Support Level | $29.19 | $10.86 |
| Resistance Level | $34.86 | $13.78 |
| Average True Range (ATR) | 0.87 | 0.61 |
| MACD | 0.06 | -0.12 |
| Stochastic Oscillator | 78.66 | 15.68 |
Price Performance
Historical ComparisonAbout DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. The company gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, and mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.